Oncobiologics - 53 Year Dividend History | OTLK
Historical dividend payout and yield for Oncobiologics (OTLK) since 1971. The current TTM dividend payout for Oncobiologics (OTLK) as of December 20, 2024 is $0.00. The current dividend yield for Oncobiologics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.035B |
$0.000B |
|
Outlook Therapeutics Inc. is a clinical-stage biopharmaceutical company. It focuses on developing ONS-5010 which is a proprietary ophthalmic bevacizumab product candidate for the treatment of wet age related macular degeneration which is in clinical stage. Outlook Therapeutics Inc., formerly known as Oncobiologics Inc., is based in Cranbury, United States.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
